March 7th 2022November 1st 2021 Shorla Oncology at CPhI Worldwide in Milan Read more at: https://www.cphi.com/europe/en/home.html
Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year FinalistsApril 24th 2024Read More Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year Finalists
FDA Considers SH-201 for Treating Certain Leukemias and CancersApril 22nd 2024Read More FDA Considers SH-201 for Treating Certain Leukemias and Cancers
FDA Accepts NDA for SH-201 in Leukemia and Other CancersApril 22nd 2024Read More FDA Accepts NDA for SH-201 in Leukemia and Other Cancers
FDA Accepts Shorla’s NDA for SH-201 to Treat Leukemia and Other CancersApril 22nd 2024Read More FDA Accepts Shorla’s NDA for SH-201 to Treat Leukemia and Other Cancers
Scaling Your Business Panel ParticipationApril 22nd 2024Read More Scaling Your Business Panel Participation